A KFF Health News analysis underscores that the terminations are sparing no part of the country, politically or ...

Travel as the greatest hurdle to overall clinical trial participation naturally impacts any efforts to improve diversity in clinical research. If the majority of potential participants are ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...